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With the introduction of sonographic and CT examinations, the number of small renal masses detected has increased. Benign
neoplastic lesions are usually smaller than 4cm in size, whilst the most common types of renal cell carcinomas have a mean size
greater than that, but we must not forget that a signiﬁcant number of small masses are renal cell carcinomas; even though the
rate of benign cases increases as the diameter of the lesions decreases, therefore, size itself cannot be used to rule out a diagnostic
of malignancy and often image characteristics are not enough to predict the nature of the lesion with certainty. In this case,
histological conﬁrmation must be recommended. Ideally, the histological study must be conducted on the surgical specimen, even
t h o u g hb i o p s yc a nb ea no p t i o ni ns e l e c t e dc a s e s .
Copyright © 2008 S. Almenar Medina and A. Calatrava Fons. This is an open access article distributed under the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
1. INTRODUCTION
Since the beginning of the eighties, with the introduction
of sonographic and CT examinations, the number of small
renal masses detected is greater than it was previously, when
they were discovered by clinical methods [1]. According to
a study conducted by The New York University Medical
Center, the number of renal masses smaller than 3cm which
were detected in a period of 5 years during the eighties was
ﬁve times greater than that found in a similar period during
the seventies [2] due to, according to Bosniak, the increase
in the number of abdominal image studies carried out and
to the systematic inclusion of kidneys in these studies. In the
Wunderlich series [3], the percentage of tumours of less than
4cm increased from 28% in 1985 to 61% in 1995.
These lesions can be sporadic or associated to hereditary
syndromes, chronic renal failure, or renal transplantation.
In the ﬁrst case, they can be detected during the course of
abdominal studies due to renal symptoms or other causes. In
thesecondcase,theyaredetectedduringtheillnesses’follow-
up or as a consequence of speciﬁc screening programmes.
In every case, masses can be solitary or multiple and
may be solid, cystic, or solid-cystic. Depending on their
cystic component in images, they can be classiﬁed into four
categories. Lesions belonging to Bosniak I y II are benign,
whereas 59% of Bosniak III and 100% of Bosniak IV are
malignant [4].
2. CYSTIC RENAL LESIONS
Renal cysts are frequent lesions of variable size, which appear
associated to diﬀerent clinical situations. Histologically, they
are lined by a single layer of cells which may be cubical in
the beginning but become more or less ﬂattened as the cyst
increases in size. However, sometimes this epithelium may
develop hyperplastic lesions, giving way to the big discussion
that exists about possible malignant transformation.
Simple renal cysts, whether solitary or multiple, are very
variable in size but are frequently smaller than 4cm. Usually,
they are autopsy incidental ﬁndings and have no clinical
relevance.
In polycystic kidney disease (dominant or recessive),
cysts have a cuboidal or ﬂattened lining which may prolif-
erate to form papillary structures inside.
In acquired renal cystic disease, which is associated to
dialysis, the majority of the cysts measure between 0.5 and
2cm, but may develop renal cell carcinomas mainly of
papillarytype.Theriskofdevelopingacarcinomainpatients2 Advances in Urology
which are undergoing dialysis is greater in those who have
developed acquired renal cystic disease [5].
3. SOLID AND COMPLEX RENAL MASSES
Solid and complex renal masses are mainly of neoplastic
origin but some inﬂammatory lesions may also have equiv-
ocal sonographic images, as it may be seen in Lebret’s series,
where 22 out of 106 studied lesions turned out to be inﬂam-
matory tissues, abscesses, or granulomatous pyelonephritis
[6]. On the other hand, most renal cell carcinomas are solid,
but 40% of them have a cystic component [7].
Some of the benign neoplastic lesions are usually smaller
than 4cm in size, but we must not forget that, to reach its
ﬁnal size, every lesion must go through this initial stage.
Therefore, size itself is not a criterion which can be used to
rule out a diagnostic of malignancy.
The most frequently detected benign neoplasms are
oncocytomas and angiomyolipomas.
Papillary adenomas are tumours with papillary or tubu-
lar architecture of low nuclear grade and 5mm in diameter
or smaller [8]. These are the most common neoplasms of
the epithelium of the renal tubules and have been found
in 40% of autopsies of patients older than 70 years. Most
papillary adenomas are silent, solitary, and occur just below
the renal capsule. Histologically, they have tubular, papillary,
or tubulopapillary architectures corresponding closely to
types 1 and 2 of papillary renal cell carcinoma. Loss of the
Y chromosome and a combined trisomy of chromosomes 7
and17aretheﬁrstgeneticalterationswecanﬁndinpapillary
tumours and the sole karyotype change in papillary tumours
from 2mm to 5mm in diameter, all with nuclear grade
1. However, it is not possible to distinguish adenomas and
carcinomas by genetic changes, because many carcinomas
show only a few genetic alterations [9]. Therefore, the
diﬀerence between low-grade papillary renal cell carcinoma
and adenoma depends mainly on size [8].
Metanephric adenoma is another solid, less frequent,
typically benign renal tumour, which ranges widely in size.
Jones et al. have reported 7 incidental cases, all of them are
less than 1cm, although symptomatic cases are usually larger
than 3cm [10].
T h em o s tc o m m o nt y p e so fr e n a lc e l lc a r c i n o m a sh a v e
a mean size which is greater than 4cm, but some unusual
types have a mean size of less than 4cm. According to Nassir,
the mean size of multilocular cystic renal cell carcinoma is
3.4cm[11] and the acquired cystic disease-associated RCC
usually has a mean size of around 3cm and shows peculiar
morphological and immunohistochemical features [12, 13].
Normally, they have a microcystic architecture and Fuhrman
grade 3. They also describe another group which they refer
to as “clear-cell papillary RCC of the end-stage kidneys.”
Papillary renal tumours with oncocytic cells of the adult
have, according to Lefevre, a mean size of 3.3cm, they
are intrarenal, with sharp edges and all, except one, have
Fuhrman grade 2 [14].
Carcinomas belonging to the hybrid oncocytic tumour
variety (which frequently occur in the Birt-Hogg-Dub´ e
syndrome) are usually of a small size and their behaviour
is between the oncocytoma and the well-diﬀerentiated
chromophobe renal cell carcinoma [15].
Finally, 10 out of the 13 tubulocystic renal cell carcino-
mas described by Yang et al. [16] measured less than 3cm.
4. RELATIONSHIP BETWEEN TUMOURAL SIZE AND
HISTOLOGICAL TYPE
One of the main problems when it comes to analysing this
relationship is that most of the small renal tumour series
are based on clinical and radiological data but histological
conﬁrmation lacks [27], especially when lesions are diag-
nosed incidentally, because the biopsy is not indicated as
a routine method [19, 22, 28]. Moreover, the series which
includes a histological study uses diﬀerent criteria to indicate
surgery or biopsy, diﬀerent cutoﬀ points for small masses,
and even diﬀerent pathologic classiﬁcations, which make it
evenmorecomplicatedtodrawgeneralconclusions(Table 1)
[5, 6, 17–25].
Nevertheless, it is clear that a signiﬁcant number of small
solid and complex masses are renal cell carcinomas and
they are, according to some authors, more frequent than
benign lesions [23, 26], even though the rate of benign cases
increases as the diameter of the lesions decreases.
In these cases, it is not possible to predict the behaviour
that the lesions will have later neither by their image
characteristics [29] nor by their growing speed throughout
a short period of time, due to the fact that this speed is not
related to the tumoural volume or to the histological grade
at a given time [18, 30]. This speed may vary throughout
time for a same tumour [31]a n dc a nb et e m p o r a r i l yz e r o ,
even though it is a carcinoma [22]. According to Kunkle,
there are no any signiﬁcant diﬀerences between tumours
with growth zero during a period of one year and those
which have positive growth during the same period at the
time of the diagnosis. In both cases, the mean size is of
2cm and 80% of the lesions of growth zero happened to be
carcinomas [17].
According to a recent study by Tabibi [32], amongst
renal cell carcinomas, there is no signiﬁcant relationship
between size and histological subtype, even though it is
true that, in long series, the size of tumours of the same
type tends to gather around a certain value. The usual
histological subtypes of renal cell carcinoma have a mean
size of more than 4cm [33] and the same happens with
t r a n s l o c a t i o nX p 1 1r e n a lc e l lc a r c i n o m a s[ 34]a n dw i t h
translocation t(6;11)(p21;q12) [35], where the mean diam-
eter is 6.8cm and 6.28cm, respectively. When carcinomas
are analysed according to size, it can be observed that when
the mean tumoural diameter increases, the ratio of papillary
carcinomas decreases and that of chromophobe carcinomas
increases (Table 2)[ 20, 23, 26].
5. RELATIONSHIP BETWEEN SIZE AND
AGGRESSIVENESS OF RENAL CELL CARCINOMAS
It cannot be categorically assured that the size of a tumour
is directly related to its histological grade and its clinical
aggressiveness. For example, low-grade tubular-mucinousS. Almenar Medina and A. Calatrava Fons 3
Table 1: Small renal masses with histological conﬁrmation. N: total number of cases; n: number of cases; RCC: renal cell carcinoma; OM:
other malignant tumors; Onc: oncocytoma; AML: angiomyolipoma; AP: papillary adenoma; OB: other benign lesions.
Size N RCC OM Onc AML AP OB
n % n % n % n % n % n %
Kunkle, 2007 [17] Median 2cm 42 37 88.1 0 0.0 4 9.5 0 0.0 0 0.0 1 2.4
Lebret, 2007 [6] Median 3cm 135 55 40.7 13 9.6 15 11.1 4 2.9 0 0.0 48 35.6
Chawla, 2006 [18]M o s t < 4cm 21 17 80.9 0 0.0 4 19.1 0 0.0 0 0.0 0 0.0
Vasudevan, 2006 [19]A l l < 5cm 70 41 58.6 6 8.6 14 20.0 9 12.9 0 0.0 0 0.0
Neuzillet, 2005 [5] Mean 3.7 c m1 5 1 28 0 . 0 0 0 . 01 6 . 700 . 016 . 716 . 7
Mindrup, 2005 [20] Mean 1.7cm 73 28 38.6 2 2.7 1 1.4 4 5.5 22 30.1 16 21.9
Volpe, 2004 [21]A l l < 4cm 9 8 88.9 0 0.0 1 11.1 0 0.0 0 0.0 0 0.0
Wehle, 2004 [22]A l l < 4cm 5 4 80.0 0 0.0 1 20.0 0 0.0 0 0.0 0 0.0
Frank, 2003 [23]A l l < 4cm 2935 2559 87.2 0 0.0 274 9.3 67 2.3 16 0.5 19 0.7
Bosniak, 1995 [24]A l l < 3.5cm 26 22 84.6 0 0.0 4 15.4 0 0.0 0 0.0 0 0.0
Silverman, 1994 [25]A l l < 3cm 35 27 77.1 2 5.7 0 0.0 1 2.9 0 0.0 5 14.3
Table 2: Distribution of histological subtypes of renal cell carcinoma depending on size. RCC: renal cell carcinoma; N:t o t a ln u m b e ro f
RCC; n: number of each subtype; RCCcc: clear cell RCC; RCCp: papillar RCC; RCCchr: chromophobe RCC.
RCC RCCcc RCCp RCCchr
Nn % N % n %
Schlomer, 2006 [26]
0-1cm 6 5 83,3 0 0,0 1 16,7
1-2cm 38 25 65,8 10 26,3 3 7,9
2-3cm 63 49 77,8 12 19,0 2 3,2
3-4cm 52 43 82,3 9 17,3 0 0,0
4-5cm 28 22 78,6 4 14,3 1 3,6
> 5cm 102 81 84,4 11 11,5 4 4,1
Mindrup, 2005 [20]
Media 1,7cm 28 7 35,0 11 68,8 0 0,0
Media 4,7cm 40 13 65,0 5 31,2 3 100,0
Frank, 2003 [23]
0-1cm 25,6 74,4 0,0
1-2cm 59,9 38,6 1,5
2-3cm 70,2 26,0 3,8
3-4cm 80,2 24,5 3,8
renalneoplasia(alsoknownasmucinoustubularandspindle
cell carcinoma) is a neoplasia with a low grade of aggressive-
ness and, nevertheless, usually has a mean diameter which
is larger than 4cm [12, 41, 42]. In addition, chromophobe
carcinomas are usually larger but less aggressive than clear
cell renal cell carcinomas [33]. In the same way, among small
renal cell carcinomas, the clear cell subtype is much more
frequent than chromophobe carcinoma (Table 3)[ 5, 6, 17–
20, 23, 25, 26, 31, 36–38].
Amongstsmallsizetumours,thereisahigherrateoflow-
grade lesions and this percentage tends to decrease as the
tumoural size increases (Table 4)[ 23, 26, 39], but we must
not forget that among carcinomas which are smaller than
4cm, there is a signiﬁcant ratio, between 6% and 50%, of
high-gradetumours(Table 5)[5,6,18,20,21,23,25,39,40].
InSchlomer’sseries[26],16.7%ofthetumourswhichare
smaller than 1cm are high-grade tumours and 38% of the 50
carcinomas with a size equal to or less than 3cm included in
H s u ’ ss e r i e s[ 39] extend beyond the renal capsule.
This last series also shows that there is no signiﬁcant
diﬀerence in grade or stage between tumours of less than
3cm and those of 3 to 5cm, but these diﬀerences do exist
between tumours of less than 5cm and those which are
greater. In the results reported by Tabibi [32], extracapsular
spread is rare in tumours of less than 4cm, but he does
not ﬁnd statistically signiﬁcant diﬀerences in grade when the
cutoﬀ point is established at 4cm. Schlomer and Miyagawa’s
results[26,43]pointtowardsthissamedirection.Thisiswhy
some authors question that the cutoﬀ point is established at
4 and not at 5cm [39, 43].4 Advances in Urology
Table 3: Percentage of histological subtypes of renal cell carcinoma in small renal masses. RCCcc: clear cell renal cell carcinoma; RCCp:
papillary renal cell carcinoma; RCCchr: chromophobe renal cell carcinoma; RCCo: other variants of renal cell carcinoma.
Size RCCcc RCCp RCCchr RCCo
n % N % n % n %
Kunkle, 2007 [17] Median 2cm 24 64,9 12 32,4 0 0,0 1 2,7
Lebret, 2007 [6] Median 3cm 41 74,5 10 18,2 4 7,3 0 0,0
Chawla, 2006 [18]M o s t < 4cm 9 52,9 7 41,2 0 0,0 1 5,9
Pankhurst, 2006 [36] 21 of them < 1mm 2 8,0 22 88,0 0 0,0 1 4,0
Schlomer, 2006 [26] Only < 4cm 122 76,7 31 19,5 6 3,8 0 0,0
Vasudevan, 2006 [19]A l l < 5cm 32 78,0 4 9,8 5 12,2 0 0,0
Neuzillet, 2005 [5] Mean 37mm 7 58,3 3 25,0 2 16,7 0 0,0
Mindrup, 2005 [20] Mean 17mm 7 25,0 11 39,3 0 0,0 10 35,7
Kato, 2004 [31]A l l < 4cm 15 83,3 3 16,7 0 0,0 0 0,0
Frank, 2003 [23]A l l < 4cm 1970 77,0 436 17,0 125 4,9 28 1,1
Shishikura,1996 [37]A l l < 2,5cm 84 86,6 3 3,1 0 0,0 10 10,3
Silverman, 1994 [25]A l l < 3cm 17 63,0 3 11,1 3 11,1 4 14,8
Yamashita, 1992 [38]A l l < 3cm 26 72,2 0 0,0 7 19,4 3 8,3
Table 4: Percentage of low-grade and high-grade carcinomas depending on size. LG: low grade; HG: high grade.
Schlomer, 2006 [26] Hsu, 2004 [39] Frank, 2003 [23]
LG % HG % LG % HG % LG % HG %
0-1cm 83,3 16,7 — — 90,9 9,1
1-2cm 94,7 5,3 — — 88,6 11,4
2-3/< 3cm 71,4 28,6 72,0 28,0 93,6 6,5
3-4cm 71,1 28,9 — — 81,3 18,7
4-5/3–5cm 67,9 32,1 67,8 32,2 77,6 22,4
5-6cm 53,8 46,2 — — 69,3 30,7
6-7/> 5cm 44,4 55,6 40,4 59,6 60,9 39,1
> 7cm 36,2 63,8 — — 37,9 62,1
6. INCIDENTAL RENAL TUMOURS
Most of the incidentally diagnosed lesions are benign. In
a classical series which studied 205 incidental lesions of
less than 1cm found in autopsies, the most common
was medullary ﬁbrous nodules (159), followed by cortical
adenoma (49), leiomyoma (12), lipoma (7), and myolipoma
(13) [44].
Renal carcinomas which are incidentally diagnosed
represent between 15 and 60% of the total number of
carcinomas, depending on the series.
Alotofthemaresmallerthan4cm[28].Generallyspeak-
ing, carcinomas discovered incidentally are smaller than
those which are symptomatic [45, 46]. Their mean diameter
is 5.7cm in contrast with the 8.7cm in symptomatic cases.
Moreover,themeansizehasreducednotablythankstoimage
techniques.Themeandiameterofrenaltumoursincidentally
found in autopsies at the University of Iowa decreased from
4.63cm in the ﬁfties to 1.65cm in the nineties [20]. They are
also associated with a lower stage and a lower nuclear grade
[47], as well as with the increasing age of patients [48].
Therefore, it would be reasonable to consider incidental
carcinomas as a group with its own clinical and pathological
signiﬁcance, even though we cannot establish at present
whether they are discovered incidentally because they still
small or because they have their own particular biological
characteristics which make them behave in a less-aggressive
way.
On the other hand, the presence of certain syndromes
mayinﬂuencethesizethatsometumoursreach,asithappens
to angiomyolipomas which have a greater mean diameter
in the context of tuberous sclerosis than when they appear
sporadically [49].
7. CONCLUSIONS
A signiﬁcant rate of small renal masses, discovered either
symptomatic or incidentally, are carcinomas. Moreover, up
to 50% of carcinomas measuring less than 4cm are high-
grade lesions and some of them extend beyond the renal
capsule despite the fact that they have got such a small
diameter. Therefore, when a small renal mass is detected, theS. Almenar Medina and A. Calatrava Fons 5
Table 5: Distribution of Fuhrman grades in renal cell carcinomas. F1, F2, F3, F4: Furhman grades.
Size RCC F1+F2 F3+F4
nn % n %
Lebret, 2007 [6] Median 3cm 57 51 89,5 6 10,5
Chawla, 2006 [18]M o s t < 4cm 17 16 94,1 1 5,9
Neuzillet, 2005 [5] Mean 37mm 12 6 50,0 6 50,0
Mindrup, 2005 [20] Only < 4cm 159 123 77,4 36 22,6
Peces, 2004 [40] Only < 4cm 12 11 91,7 1 8,3
Hsu, 2004 [39] Only < 3cm 50 36 72,0 14 28,0
Volpe, 2004 [21]A l l < 4cm 8 4 50,0 4 50,0
Frank, 2003 [23] Only < 4cm 480 420 87,5 60 12,5
Silverman, 1994 [25]A l l < 3cm 27 24 88,9 3 11,1
size itself is not a reliable feature to rule out a diagnostic
of malignancy. Unfortunately, there are many times when
image characteristics or speed of growth along a period of
several months are not enough to predict the nature of the
lesionwithcertainty.Inthesecases,histologicalconﬁrmation
must be recommended.
Most of the times, the histological study is conducted on
the surgical specimen, though biopsy can be considered a
good option if surgery represents a high risk for the patient.
The problem is that the smaller a mass is, the more diﬃcult
it is to get the right sample; but the bigger it is, the less
representative the whole of the lesion is. That is why there
is no general agreement about biopsy indications at the
moment. On the other hand, surgical resection in the early
stage of the tumour is still the best treatment option for
renal cell cancer, and small masses are good candidates for
conservative techniques. From this point of view, surgery
implies a double beneﬁt because it is a good therapeutic
choice and provides the most accurate diagnosis.
Risks and beneﬁts must be evaluated in every single
case taking into account the particular clinical situation of
the patient as well as the available technical means and the
expertise of the medical team involved.
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